Page 25

Mayo_2017

ARTÍCULO DE INVESTIGACIÓN 571 24. Bhargava M, Cheung C, Sabanayagam C, Kawasaki R, Harper C, Lamoureux E, et al. Accuracy of diabetic retinopathy screening by trained non-physician graders using non-mydriatic fundus camera. Singapore Med J 2012; 53: 715-9. 25. Schütt F, Bruckner T, Schäfer K, Lehnhoff D, Rudofsky G, Kasperk C, et al. Fundus screening by medical technicians. Ophthalmology 2013; 110 (2): 154-9. 26. Harris M. The NHS Diabetic Eye Screening Programme: New Common Pathway. The Royal College of Ophthalmologists. London: Focus; 2012. 27. Williams R, Airey M, Baxter H, Forrester J, Kennedy Martin T, Girach A. Epidemiology of diabetic retinopathy and macular oedema: a systematic review.  Eye. 2004; 18 (10): 963-83. 28. Wells J, Glassman A, Ayala A, Jampol L, Aiello L, Antoszyk A, et al. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med 2015; 372 (13): 1193-203. 29. Stefansson E, Bek T, Porta M, Larsen N, Kristinsson JK, Agardh E. Screening and prevention of diabetic blindness. Acta Ophthalmologica Scandinavica 2000; 78 (4): 374-85. 30. Liew G, Michaelides M, Bunce C. A comparison of the causes of blindness Certifications in England and Wales in working age adults (16-64 years), 1999-2000 with 2009-2010. BMJ Open 2014; 4: e004015. 31. Scanlon P, Carter S, Foy C, Husband R, Abbas J, Bachmann M. Diabetic retinopathy and socioeconomic deprivation in Gloucestershire. Journal of Medical Screening 2008; 15 (3): 118-21. 32. Leese G, Boyle P, Feng Z, Emslie-Smith A, Ellis J. Screening uptake in a well-established diabetic retinopathy screening program: the role of geographical access and deprivation. Diabetes Care 2008; 31 (11): 2131-5. Prevalencia de retinopatía diabética en APS - T. Covarrubias et al Rev Med Chile 2017; 145: 564-571


Mayo_2017
To see the actual publication please follow the link above